A significant portion of recent cancer research focuses on the genomic landscape of cancer. By analyzing the genetic mutations and alterations in cancer cells, researchers gain insights into tumor development and progression. Studies have shown that identifying specific genetic mutations can help in tailoring personalized treatment plans. The use of next-generation sequencing has revolutionized this area, providing a detailed view of the cancer genome and leading to the discovery of new therapeutic targets.
